REGENXBIO is focused on developing therapies for diseases that have significant unmet needs.
Gene therapy has the potential to address the underlying cause of disease, providing single-dose therapies with long-lasting results. Our management team includes leaders who are experienced in building and operating innovative healthcare ventures and have expert knowledge in the development of AAV gene therapy.
